- Home
- KMI vs SNN Comparison
KMI vs SNN Comparison
Compare KMI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMI
- SNN
- Stock Information
- Founded
- KMI 1936
- SNN 1856
- Country
- KMI United States
- SNN United Kingdom
- Employees
- KMI N/A
- SNN N/A
- Industry
- KMI Natural Gas Distribution
- SNN Industrial Specialties
- Sector
- KMI Utilities
- SNN Health Care
- Exchange
- KMI Nasdaq
- SNN Nasdaq
- Market Cap
- KMI 52.4B
- SNN 12.4B
- IPO Year
- KMI 2011
- SNN 1999
- Fundamental
- Price
- KMI $24.82
- SNN $29.44
- Analyst Decision
- KMI Buy
- SNN Strong Buy
- Analyst Count
- KMI 13
- SNN 1
- Target Price
- KMI $24.92
- SNN N/A
- AVG Volume (30 Days)
- KMI 14.3M
- SNN 674.7K
- Earning Date
- KMI 10-16-2024
- SNN 08-01-2024
- Dividend Yield
- KMI 4.63%
- SNN 2.55%
- EPS Growth
- KMI 3.81
- SNN 39.77
- EPS
- KMI 1.13
- SNN 0.35
- Revenue
- KMI $15,151,000,000.00
- SNN $5,642,000,000.00
- Revenue This Year
- KMI $3.78
- SNN $6.92
- Revenue Next Year
- KMI $4.96
- SNN $5.43
- P/E Ratio
- KMI $21.90
- SNN $41.81
- Revenue Growth
- KMI N/A
- SNN 5.48
- 52 Week Low
- KMI $15.91
- SNN $21.53
- 52 Week High
- KMI $25.43
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- KMI 74.01
- SNN 46.87
- Support Level
- KMI $24.50
- SNN $28.26
- Resistance Level
- KMI $25.01
- SNN $29.64
- Average True Range (ATR)
- KMI 0.48
- SNN 0.36
- MACD
- KMI 0.06
- SNN 0.05
- Stochastic Oscillator
- KMI 76.89
- SNN 58.65
About KMI Kinder Morgan Inc.
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 82,000 miles in pipelines and 139 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.